EMEA (Europe, Middle East and Africa) Human Growth Hormone Drugs Market Report 2018

March 2018 | 103 pages | ID: EC05C74CCF5QEN
QYResearch

Abstracts

In this report, the EMEA Human Growth Hormone Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Human Growth Hormone Drugs for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Human Growth Hormone Drugs market competition by top manufacturers/players, with Human Growth Hormone Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Eli Lilly and Company (US)
• Ferring Holding SA (Switzerland)
• Genentech, Inc. (US)
• GeneScience Pharmaceuticals Co., Ltd. (China)
• Merck KgaA (Germany)
• Novo Nordisk A/S (Denmark)
• Pfizer, Inc. (US)
• Sandoz International GmbH (Germany)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Norditropin
• Genotropin
• Humatrope
• Saizen
• Omnitrope - the Somatropin Biosimilar
• Somatropin Biopartners

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Prader-Willi Syndrome
• Turner Syndrome
• Short Stature Homeobox Gene
• Small for Gestational Age
• Chronic Renal Insufficiency
• Short Bowel Syndrome

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Human Growth Hormone Drugs Market Report 2018

1 HUMAN GROWTH HORMONE DRUGS OVERVIEW

1.1 Product Overview and Scope of Human Growth Hormone Drugs
1.2 Classification of Human Growth Hormone Drugs
  1.2.1 EMEA Human Growth Hormone Drugs Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Human Growth Hormone Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Norditropin
  1.2.4 Genotropin
  1.2.5 Humatrope
  1.2.6 Saizen
  1.2.7 Omnitrope - the Somatropin Biosimilar
  1.2.8 Somatropin Biopartners
1.3 EMEA Human Growth Hormone Drugs Market by Application/End Users
  1.3.1 EMEA Human Growth Hormone Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Prader-Willi Syndrome
  1.3.3 Turner Syndrome
  1.3.4 Short Stature Homeobox Gene
  1.3.5 Small for Gestational Age
  1.3.6 Chronic Renal Insufficiency
  1.3.7 Short Bowel Syndrome
1.4 EMEA Human Growth Hormone Drugs Market by Region
  1.4.1 EMEA Human Growth Hormone Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Human Growth Hormone Drugs (2013-2025)
  1.5.1 EMEA Human Growth Hormone Drugs Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Human Growth Hormone Drugs Revenue and Growth Rate (2013-2025)

2 EMEA HUMAN GROWTH HORMONE DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Human Growth Hormone Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Human Growth Hormone Drugs Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Human Growth Hormone Drugs Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Human Growth Hormone Drugs Sale Price by Players (2013-2018)
2.2 EMEA Human Growth Hormone Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Human Growth Hormone Drugs Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Human Growth Hormone Drugs Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Human Growth Hormone Drugs Sale Price by Type (2013-2018)
2.3 EMEA Human Growth Hormone Drugs (Volume) by Application
2.4 EMEA Human Growth Hormone Drugs (Volume and Value) by Region
  2.4.1 EMEA Human Growth Hormone Drugs Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Human Growth Hormone Drugs Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Human Growth Hormone Drugs Sales Price by Region (2013-2018)

3 EUROPE HUMAN GROWTH HORMONE DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Human Growth Hormone Drugs Sales and Value (2013-2018)
  3.1.1 Europe Human Growth Hormone Drugs Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Human Growth Hormone Drugs Revenue and Growth Rate (2013-2018)
3.2 Europe Human Growth Hormone Drugs Sales and Market Share by Type
3.3 Europe Human Growth Hormone Drugs Sales and Market Share by Application
3.4 Europe Human Growth Hormone Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Human Growth Hormone Drugs Sales Volume by Countries (2013-2018)
  3.4.2 Europe Human Growth Hormone Drugs Revenue by Countries (2013-2018)
  3.4.3 Germany Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
  3.4.4 France Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
  3.4.5 UK Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
  3.4.6 Russia Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
  3.4.7 Italy Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)

4 MIDDLE EAST HUMAN GROWTH HORMONE DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Human Growth Hormone Drugs Sales and Value (2013-2018)
  4.1.1 Middle East Human Growth Hormone Drugs Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Human Growth Hormone Drugs Revenue and Growth Rate (2013-2018)
4.2 Middle East Human Growth Hormone Drugs Sales and Market Share by Type
4.3 Middle East Human Growth Hormone Drugs Sales and Market Share by Application
4.4 Middle East Human Growth Hormone Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Human Growth Hormone Drugs Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Human Growth Hormone Drugs Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
  4.4.4 Israel Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
  4.4.5 UAE Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
  4.4.6 Iran Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)

5 AFRICA HUMAN GROWTH HORMONE DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Human Growth Hormone Drugs Sales and Value (2013-2018)
  5.1.1 Africa Human Growth Hormone Drugs Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Human Growth Hormone Drugs Revenue and Growth Rate (2013-2018)
5.2 Africa Human Growth Hormone Drugs Sales and Market Share by Type
5.3 Africa Human Growth Hormone Drugs Sales and Market Share by Application
5.4 Africa Human Growth Hormone Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Human Growth Hormone Drugs Sales Volume by Countries (2013-2018)
  5.4.2 Africa Human Growth Hormone Drugs Revenue by Countries (2013-2018)
  5.4.3 South Africa Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)

6 EMEA HUMAN GROWTH HORMONE DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Eli Lilly and Company (US)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Growth Hormone Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Ferring Holding SA (Switzerland)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Human Growth Hormone Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Genentech, Inc. (US)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Human Growth Hormone Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 GeneScience Pharmaceuticals Co., Ltd. (China)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Human Growth Hormone Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Merck KgaA (Germany)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Human Growth Hormone Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Novo Nordisk A/S (Denmark)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Human Growth Hormone Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Pfizer, Inc. (US)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Human Growth Hormone Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Sandoz International GmbH (Germany)
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Human Growth Hormone Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview

7 HUMAN GROWTH HORMONE DRUGS MANUFACTURING COST ANALYSIS

7.1 Human Growth Hormone Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Growth Hormone Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Growth Hormone Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Growth Hormone Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA HUMAN GROWTH HORMONE DRUGS MARKET FORECAST (2018-2025)

11.1 EMEA Human Growth Hormone Drugs Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Human Growth Hormone Drugs Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Human Growth Hormone Drugs Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Human Growth Hormone Drugs Price and Trend Forecast (2018-2025)
11.2 EMEA Human Growth Hormone Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Human Growth Hormone Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Human Growth Hormone Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Human Growth Hormone Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Human Growth Hormone Drugs Sales Forecast by Type (2018-2025)
11.7 EMEA Human Growth Hormone Drugs Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Human Growth Hormone Drugs
Figure EMEA Human Growth Hormone Drugs Sales Volume (K Pcs) by Type (2013-2025)
Figure EMEA Human Growth Hormone Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Norditropin Product Picture
Figure Genotropin Product Picture
Figure Humatrope Product Picture
Figure Saizen Product Picture
Figure Omnitrope - the Somatropin Biosimilar Product Picture
Figure Somatropin Biopartners Product Picture
Figure EMEA Human Growth Hormone Drugs Sales Volume (K Pcs) by Application (2013-2025)
Figure EMEA Sales Market Share of Human Growth Hormone Drugs by Application in 2017
Figure Prader-Willi Syndrome Examples
Table Key Downstream Customer in Prader-Willi Syndrome
Figure Turner Syndrome Examples
Table Key Downstream Customer in Turner Syndrome
Figure Short Stature Homeobox Gene Examples
Table Key Downstream Customer in Short Stature Homeobox Gene
Figure Small for Gestational Age Examples
Table Key Downstream Customer in Small for Gestational Age
Figure Chronic Renal Insufficiency Examples
Table Key Downstream Customer in Chronic Renal Insufficiency
Figure Short Bowel Syndrome Examples
Table Key Downstream Customer in Short Bowel Syndrome
Figure EMEA Human Growth Hormone Drugs Market Size (Million USD) by Region (2013-2025)
Figure Europe Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Human Growth Hormone Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Human Growth Hormone Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Human Growth Hormone Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Human Growth Hormone Drugs Sales Volume and Growth Rate (2013-2025)
Figure EMEA Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Human Growth Hormone Drugs Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table EMEA Human Growth Hormone Drugs Sales Volume (K Pcs) of Major Players (2013-2018)
Table EMEA Human Growth Hormone Drugs Sales Share by Players (2013-2018)
Figure 2017 Human Growth Hormone Drugs Sales Share by Players
Figure 2017 Human Growth Hormone Drugs Sales Share by Players
Figure EMEA Human Growth Hormone Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Human Growth Hormone Drugs Revenue (Million USD) by Players (2013-2018)
Table EMEA Human Growth Hormone Drugs Revenue Share by Players (2013-2018)
Table 2017 EMEA Human Growth Hormone Drugs Revenue Share by Players
Table 2017 EMEA Human Growth Hormone Drugs Revenue Share by Players
Table EMEA Human Growth Hormone Drugs Sale Price (USD/Pcs) by Players (2013-2018)
Table EMEA Human Growth Hormone Drugs Sales (K Pcs) and Market Share by Type (2013-2018)
Table EMEA Human Growth Hormone Drugs Sales Share by Type (2013-2018)
Figure Sales Market Share of Human Growth Hormone Drugs by Type (2013-2018)
Figure EMEA Human Growth Hormone Drugs Sales Market Share by Type (2013-2018)
Table EMEA Human Growth Hormone Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Human Growth Hormone Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Human Growth Hormone Drugs by Type in 2017
Table EMEA Human Growth Hormone Drugs Sale Price (USD/Pcs) by Type (2013-2018)
Table EMEA Human Growth Hormone Drugs Sales (K Pcs) and Market Share by Application (2013-2018)
Table EMEA Human Growth Hormone Drugs Sales Share by Application (2013-2018)
Figure Sales Market Share of Human Growth Hormone Drugs by Application (2013-2018)
Figure EMEA Human Growth Hormone Drugs Sales Market Share by Application in 2017
Table EMEA Human Growth Hormone Drugs Sales (K Pcs) and Market Share by Region (2013-2018)
Table EMEA Human Growth Hormone Drugs Sales Share by Region (2013-2018)
Figure Sales Market Share of Human Growth Hormone Drugs by Region (2013-2018)
Figure EMEA Human Growth Hormone Drugs Sales Market Share in 2017
Table EMEA Human Growth Hormone Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Human Growth Hormone Drugs Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Human Growth Hormone Drugs by Region (2013-2018)
Figure EMEA Human Growth Hormone Drugs Revenue Market Share Regions in 2017
Table EMEA Human Growth Hormone Drugs Sales Price (USD/Pcs) by Region (2013-2018)
Figure Europe Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Human Growth Hormone Drugs Revenue and Growth Rate (2013-2018)
Table Europe Human Growth Hormone Drugs Sales (K Pcs) by Type (2013-2018)
Table Europe Human Growth Hormone Drugs Market Share by Type (2013-2018)
Figure Europe Human Growth Hormone Drugs Market Share by Type in 2017
Table Europe Human Growth Hormone Drugs Sales (K Pcs) by Application (2013-2018)
Table Europe Human Growth Hormone Drugs Market Share by Application (2013-2018)
Figure Europe Human Growth Hormone Drugs Market Share by Application in 2017
Table Europe Human Growth Hormone Drugs Sales (K Pcs) by Countries (2013-2018)
Table Europe Human Growth Hormone Drugs Sales Market Share by Countries (2013-2018)
Figure Europe Human Growth Hormone Drugs Sales Market Share by Countries (2013-2018)
Figure Europe Human Growth Hormone Drugs Sales Market Share by Countries in 2017
Table Europe Human Growth Hormone Drugs Revenue (Million USD) by Countries (2013-2018)
Table Europe Human Growth Hormone Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Human Growth Hormone Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Human Growth Hormone Drugs Revenue Market Share by Countries in 2017
Figure Germany Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure France Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure UK Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Russia Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Italy Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Benelux Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Human Growth Hormone Drugs Sales (K Pcs) by Type (2013-2018)
Table Middle East Human Growth Hormone Drugs Market Share by Type (2013-2018)
Figure Middle East Human Growth Hormone Drugs Market Share by Type (2013-2018)
Table Middle East Human Growth Hormone Drugs Sales (K Pcs) by Applications (2013-2018)
Table Middle East Human Growth Hormone Drugs Market Share by Applications (2013-2018)
Figure Middle East Human Growth Hormone Drugs Sales Market Share by Application in 2017
Table Middle East Human Growth Hormone Drugs Sales Volume (K Pcs) by Countries (2013-2018)
Table Middle East Human Growth Hormone Drugs Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Human Growth Hormone Drugs Sales Volume Market Share by Countries in 2017
Table Middle East Human Growth Hormone Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East Human Growth Hormone Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East Human Growth Hormone Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East Human Growth Hormone Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Israel Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure UAE Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Iran Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Human Growth Hormone Drugs Sales (K Pcs) by Type (2013-2018)
Table Africa Human Growth Hormone Drugs Sales Market Share by Type (2013-2018)
Figure Africa Human Growth Hormone Drugs Sales Market Share by Type (2013-2018)
Figure Africa Human Growth Hormone Drugs Sales Market Share by Type in 2017
Table Africa Human Growth Hormone Drugs Sales (K Pcs) by Application (2013-2018)
Table Africa Human Growth Hormone Drugs Sales Market Share by Application (2013-2018)
Figure Africa Human Growth Hormone Drugs Sales Market Share by Application (2013-2018)
Table Africa Human Growth Hormone Drugs Sales Volume (K Pcs) by Countries (2013-2018)
Table Africa Human Growth Hormone Drugs Sales Market Share by Countries (2013-2018)
Figure Africa Human Growth Hormone Drugs Sales Market Share by Countries (2013-2018)
Figure Africa Human Growth Hormone Drugs Sales Market Share by Countries in 2017
Table Africa Human Growth Hormone Drugs Revenue (Million USD) by Countries (2013-2018)
Table Africa Human Growth Hormone Drugs Revenue Market Share by Countries (2013-2018)
Figure Africa Human Growth Hormone Drugs Revenue Market Share by Countries (2013-2018)
Figure Africa Human Growth Hormone Drugs Revenue Market Share by Countries in 2017
Figure South Africa Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Nigeria Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Egypt Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Algeria Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Table Eli Lilly and Company (US) Human Growth Hormone Drugs Basic Information List
Table Eli Lilly and Company (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eli Lilly and Company (US) Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Eli Lilly and Company (US) Human Growth Hormone Drugs Sales Market Share in EMEA (2013-2018)
Figure Eli Lilly and Company (US) Human Growth Hormone Drugs Revenue Market Share in EMEA (2013-2018)
Table Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Basic Information List
Table Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales Market Share in EMEA (2013-2018)
Figure Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Revenue Market Share in EMEA (2013-2018)
Table Genentech, Inc. (US) Human Growth Hormone Drugs Basic Information List
Table Genentech, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genentech, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Genentech, Inc. (US) Human Growth Hormone Drugs Sales Market Share in EMEA (2013-2018)
Figure Genentech, Inc. (US) Human Growth Hormone Drugs Revenue Market Share in EMEA (2013-2018)
Table GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Basic Information List
Table GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales Market Share in EMEA (2013-2018)
Figure GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Revenue Market Share in EMEA (2013-2018)
Table Merck KgaA (Germany) Human Growth Hormone Drugs Basic Information List
Table Merck KgaA (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck KgaA (Germany) Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Merck KgaA (Germany) Human Growth Hormone Drugs Sales Market Share in EMEA (2013-2018)
Figure Merck KgaA (Germany) Human Growth Hormone Drugs Revenue Market Share in EMEA (2013-2018)
Table Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Basic Information List
Table Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales Market Share in EMEA (2013-2018)
Figure Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Revenue Market Share in EMEA (2013-2018)
Table Pfizer, Inc. (US) Human Growth Hormone Drugs Basic Information List
Table Pfizer, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Pfizer, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Pfizer, Inc. (US) Human Growth Hormone Drugs Sales Market Share in EMEA (2013-2018)
Figure Pfizer, Inc. (US) Human Growth Hormone Drugs Revenue Market Share in EMEA (2013-2018)
Table Sandoz International GmbH (Germany) Human Growth Hormone Drugs Basic Information List
Table Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2018)
Figure Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales Market Share in EMEA (2013-2018)
Figure Sandoz International GmbH (Germany) Human Growth Hormone Drugs Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Growth Hormone Drugs
Figure Manufacturing Process Analysis of Human Growth Hormone Drugs
Figure Human Growth Hormone Drugs Industrial Chain Analysis
Table Raw Materials Sources of Human Growth Hormone Drugs Major Manufacturers in 2017
Table Major Buyers of Human Growth Hormone Drugs
Table Distributors/Traders List
Figure EMEA Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure EMEA Human Growth Hormone Drugs Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Human Growth Hormone Drugs Price (USD/Pcs) and Trend Forecast (2018-2025)
Table EMEA Human Growth Hormone Drugs Sales (K Pcs) Forecast by Region (2018-2025)
Figure EMEA Human Growth Hormone Drugs Sales Market Share Forecast by Region (2018-2025)
Table EMEA Human Growth Hormone Drugs Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Human Growth Hormone Drugs Revenue Market Share Forecast by Region (2018-2025)
Table Europe Human Growth Hormone Drugs Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Europe Human Growth Hormone Drugs Sales Market Share Forecast by Countries (2018-2025)
Table Europe Human Growth Hormone Drugs Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Human Growth Hormone Drugs Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Human Growth Hormone Drugs Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Middle East Human Growth Hormone Drugs Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Human Growth Hormone Drugs Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Human Growth Hormone Drugs Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Human Growth Hormone Drugs Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Africa Human Growth Hormone Drugs Sales Market Share Forecast by Countries (2018-2025)
Table Africa Human Growth Hormone Drugs Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Human Growth Hormone Drugs Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Human Growth Hormone Drugs Sales (K Pcs) Forecast by Type (2018-2025)
Figure EMEA Human Growth Hormone Drugs Sales Market Share Forecast by Type (2018-2025)
Table EMEA Human Growth Hormone Drugs Sales (K Pcs) Forecast by Application (2018-2025)
Figure EMEA Human Growth Hormone Drugs Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources